4.5 Review

Drug-resistant epilepsy: Definition, pathophysiology, and management

Related references

Note: Only part of the references are listed.
Article Behavioral Sciences

Determinants of medication adherence in people with epilepsy: A multicenter, cross-sectional survey

F. Narducci et al.

Summary: Poor medication adherence is a critical challenge for clinicians in managing epilepsy patients. This study assessed the relationship between demographic, clinical, and neuropsychological factors and medication adherence in a population of 200 epilepsy patients. The results showed that female gender and older age were associated with better medication adherence. These findings could contribute to the development of decisional support systems in outpatient epilepsy clinics.

EPILEPSY & BEHAVIOR (2023)

Review Clinical Neurology

Emerging approaches in neurostimulation for epilepsy

Brian Nils Lundstrom et al.

Summary: This article summarizes recent approaches in neurostimulation for epilepsy patients and provides a perspective on its future. Various methods of neurostimulation, including vagus nerve stimulation and deep brain stimulation, have been studied. Hardware improvements and noninvasive brain stimulation techniques offer potential benefits for treating epilepsy patients.

CURRENT OPINION IN NEUROLOGY (2023)

Review Pharmacology & Pharmacy

Fenfluramine: A Review in Dravet and Lennox-Gastaut Syndromes

James E. Frampton

Summary: Fintepla is an oral anti-seizure medication with a novel mechanism of action. It has been shown to reduce seizure frequency in patients with Dravet syndrome and Lennox-Gastaut syndrome, and may also improve everyday executive functioning in some patients.

DRUGS (2023)

Article Medicine, General & Internal

Individualized Prediction of Drug Resistance in People with Post-Stroke Epilepsy: A Retrospective Study

Simona Lattanzi et al.

Summary: This study aimed to develop a model and nomogram to predict drug resistance in patients with post-stroke epilepsy (PSE). The study identified age, intracerebral hemorrhage, stroke severity, latency of PSE, and status epilepticus as independent predictors of drug resistance. The nomogram showed good predictive accuracy and may serve as a practical tool for personalized prediction of drug-resistant PSE.

JOURNAL OF CLINICAL MEDICINE (2023)

Review Clinical Neurology

Evaluation of the Patient With Paroxysmal Spells Mimicking Epileptic Seizures

Anteneh M. Feyissa et al.

Summary: The diagnostic issue of paroxysmal spells, including epileptic seizure (ES) mimics, is common and challenging for neurologists. This review provides an up-to-date overview of the most common causes of ES mimics encountered in outpatient settings. Distinguishing between epileptic and non-epileptic spells is crucial to prevent unnecessary treatment and healthcare resource overuse.

NEUROLOGIST (2023)

Article Clinical Neurology

Definition of drug-resistant epilepsy: A reappraisal based on epilepsy types

Ali A. Asadi-Pooya et al.

Summary: This study aims to re-assess the definition of drug-resistant epilepsy based on a large-scale, long-term study including both adults and children. The study found that the definition of drug-resistant epilepsy should differ across different epilepsy types, and provided indicators for each type.

ACTA NEUROLOGICA SCANDINAVICA (2022)

Article Clinical Neurology

Efficacy of cenobamate for uncontrolled focal seizures in patients with previous epilepsy-related surgery: Post hoc analysis of a phase 3, multicenter, open-label study

Bassel Abou-Khalil et al.

Summary: This post hoc analysis evaluated the efficacy of cenobamate in patients with prior epilepsy-related surgery and found that cenobamate is effective in treating refractory focal seizures in these patients. The findings suggest that cenobamate may be considered early in the treatment regimen, potentially before surgery is considered.

EPILEPSY RESEARCH (2022)

Article Clinical Neurology

Latency of poststroke epilepsy can predict drug resistance

Simona Lattanzi et al.

Summary: This study found that the time from stroke to epilepsy onset is significantly related to the risk of drug resistance, with the highest risk occurring within the first few months after stroke and gradually decreasing thereafter.

EUROPEAN JOURNAL OF NEUROLOGY (2022)

Article Clinical Neurology

Black Line Sign in Focal Cortical Dysplasia IIB A 7T MRI and Electroclinicopathologic Study

Yingying Tang et al.

Summary: The black line sign is a novel MRI marker for focal cortical dysplasia (FCD) IIB. This study provides detailed imaging-electroclinicopathologic characterization of the black line sign and its association with seizure freedom in FCD IIB patients.

NEUROLOGY (2022)

Article Neurosciences

Risk factors for Drug-resistant Epilepsy (DRE) and a nomogram model to predict DRE development in post-traumatic epilepsy patients

Tingting Yu et al.

Summary: This study aimed to identify factors affecting the development of drug-resistant epilepsy (DRE) and establish a reliable nomogram to predict DRE development in patients with post-traumatic epilepsy (PTE). Through a retrospective clinical analysis, it was found that age at PTE, seizure type, status epilepticus (SE), and electroencephalogram (EEG) findings were independent predictors of DRE development. A nomogram was created using these predictors' coefficients to calculate the probability of DRE.

CNS NEUROSCIENCE & THERAPEUTICS (2022)

Article Behavioral Sciences

Prevalence, risk factors, and prognosis of drug-resistant epilepsy in autoimmune encephalitis

Robb Wesselingh et al.

Summary: This study evaluated the prevalence and biomarkers of drug-resistant epilepsy (DRE) in patients with autoimmune encephalitis (AIE). The results showed that 16% of AIE patients developed DRE at 12-month follow-up. The presence of status epilepticus, temporal lobe focality, and periodic discharges on the admission EEG were associated with the development of DRE at 12 months.

EPILEPSY & BEHAVIOR (2022)

Review Neurosciences

Centromedian thalamic neuromodulation for the treatment of idiopathic generalized epilepsy

Andrew J. Zillgitt et al.

Summary: Idiopathic generalized epilepsy (IGE) is a common type of epilepsy, and traditional medications are not always effective. Deep brain stimulation (DBS) and responsive neurostimulation (RNS) may be potential surgical treatments for IGE, although there is limited data available. Promising results have been reported in published studies.

FRONTIERS IN HUMAN NEUROSCIENCE (2022)

Review Medicine, General & Internal

Individualised prediction of drug resistance and seizure recurrence after medication withdrawal in people with juvenile myoclonic epilepsy: A systematic review and individual participant data meta-analysis

Remi Stevelink et al.

Summary: This study aimed to identify predictors of drug resistance and seizure recurrence in people with juvenile myoclonic epilepsy (JME) to allow for individualized prediction of treatment outcomes. The study found multiple factors associated with drug resistance and seizure recurrence and provided personalized prediction tools.

ECLINICALMEDICINE (2022)

Article Behavioral Sciences

Recent developments in stereo electroencephalography monitoring for epilepsy surgery

Debopam Samanta

Summary: The utilization of the stereo electroencephalography (SEEG) method has recently grown globally and it is now the preferred method for epilepsy monitoring. Recent advancements in electrode implantation, data interpretation, and therapeutic strategy have made SEEG a more accessible and effective approach.

EPILEPSY & BEHAVIOR (2022)

Review Pharmacology & Pharmacy

Current and future pharmacotherapy options for drug-resistant epilepsy

Samia Elkommos et al.

Summary: This article reviews current and future pharmacotherapy options for the treatment of drug-resistant epilepsy. Several drugs are currently being used or under development, including those for specific epilepsy syndromes. Many compounds are still in the preclinical or clinical development stages and show promise for future treatments.

EXPERT OPINION ON PHARMACOTHERAPY (2022)

Review Neurosciences

Potential clinical and biochemical markers for the prediction of drug-resistant epilepsy: A literature review

ZhiQiang Li et al.

Summary: Drug resistance is a major challenge in epilepsy treatment, and there is currently no standard predictor to guide clinical management. Researchers are working on developing reliable potential predictors.

NEUROBIOLOGY OF DISEASE (2022)

Article Clinical Neurology

Dietary Treatments for Epilepsy

Babitha Haridas et al.

NEUROLOGIC CLINICS (2022)

Article Clinical Neurology

Emerging Technologies for Epilepsy Surgery

Danika L. Paulo et al.

Summary: Surgical treatment options can improve patients' quality of life and reduce disease-related morbidity and mortality when medical treatments fail to provide seizure freedom. Approximately 30% to 40% of patients with epilepsy experience drug-resistant seizures and should be referred to a comprehensive epilepsy center for evaluation and consideration of surgical treatment options. However, epilepsy surgery remains underutilized, partly due to surgical risk and inefficient referral patterns.

NEUROLOGIC CLINICS (2022)

Article Pediatrics

Development and validation of a nomogram for the early prediction of drug resistance in children with epilepsy

Hua Geng et al.

Summary: A nomogram prediction model for drug-resistant epilepsy (DRE) in children was developed and validated in this study. The model showed good discrimination and calibration, and it can aid in the timely identification of DRE in children, improving patient prognosis.

FRONTIERS IN PEDIATRICS (2022)

Article Behavioral Sciences

Drug-resistant epilepsy: From multiple hypotheses to an integral explanation using preclinical resources

Daniel Perez-Perez et al.

Summary: Drug-resistant epilepsy affects a significant number of patients, with no universal explanation for its occurrence. Experimental models have limitations and there is a need for a comprehensive global hypothesis to address this issue.

EPILEPSY & BEHAVIOR (2021)

Article Clinical Neurology

Long-term medical and social outcomes of patients with Lennox-Gastaut syndrome

Ali A. Asadi-Pooya et al.

Summary: In this study, it was found that only a minority of patients with LGS (about one in six) may achieve a seizure-free state in their adulthood, but very few of them could enjoy a healthy social life. While intellectual dysfunction may not be evident at the onset of the disease, cognitive impairment usually becomes apparent over time, and almost all patients would suffer from poor social outcomes in their adulthood.

EPILEPSY RESEARCH (2021)

Review Clinical Neurology

MicroRNAs in temporal lobe epilepsy: a systematic review

Ali A. Asadi-Pooya et al.

Summary: This review systematically examined the potential applications of microRNAs as biomarkers in drug-resistant temporal lobe epilepsy. While three studies provided some evidence, challenges remain before microRNAs can be translated into clinical practice for the diagnosis of drug-resistant TLE.

NEUROLOGICAL SCIENCES (2021)

Article Clinical Neurology

Cluster analysis of a large dataset of patients with Lennox-Gastaut syndrome

Ali A. Asadi-Pooya et al.

Summary: The study identified three distinct clusters of patients with LGS using Two-Step cluster analysis, showing significant differences in seizure outcomes between these clusters.

SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2021)

Article Clinical Neurology

The SANTe study at 10 years of follow-up: Effectiveness, safety, and sudden unexpected death in epilepsy

Vicenta Salanova et al.

Summary: This study evaluated the long-term efficacy and safety of deep brain stimulation (DBS) for epilepsy, showing favorable outcomes with stable results. Reduction in frequency of the most severe seizure type may lower the risk of SUDEP. The SUDEP rate with DBS (2.0) is comparable to other neuromodulation treatments for drug-resistant focal epilepsy.

EPILEPSIA (2021)

Review Clinical Neurology

New Trends and Most Promising Therapeutic Strategies for Epilepsy Treatment

Antonella Riva et al.

Summary: Despite the widespread availability of novel anti-seizure medications, a significant portion of epilepsy patients still experience persistent seizures, indicating the need for more precise treatment strategies. Approaches towards precision medicine, including personalized drug selection and innovative interventions like gene therapy, are at the forefront of research efforts to better address the challenges of epilepsy. Further studies are required to validate the efficacy and safety of these novel therapeutic approaches in improving patient outcomes.

FRONTIERS IN NEUROLOGY (2021)

Article Neurosciences

Predictors of Pharmaco-Resistance in Patients with Post-Stroke Epilepsy

Simona Lattanzi et al.

Summary: The study found that approximately 20% of patients with post-stroke epilepsy develop pharmaco-resistance, which is associated with younger age at stroke onset, stroke type and severity, occurrence of status epilepticus, and seizure types.

BRAIN SCIENCES (2021)

Article Medicine, General & Internal

A Scale for Predicting the Outcomes of Patients with Epilepsy: A Study of 141 Cases

Xu Chen et al.

Summary: The study aimed to develop a scale (SEPE) to estimate the prognosis of patients with epilepsy. The scale was able to differentiate between different outcomes for patients and help in assessing the disease condition and treatment direction.

INTERNATIONAL JOURNAL OF GENERAL MEDICINE (2021)

Review Clinical Neurology

MicroRNAs in the development of resistance to antiseizure drugs and their potential as biomarkers in pharmacoresistant epilepsy

Julia Bohosova et al.

Summary: Despite the development of many new antiseizure drugs in the past decade, a significant percentage of patients remain pharmacoresistant. Predicting therapeutic response and identifying biomarkers for pharmacoresistant patients are crucial tasks, with miRNAs emerging as potential new biomarkers in epilepsy.

EPILEPSIA (2021)

Review Clinical Neurology

Clinical Management of Drug Resistant Epilepsy: A Review on Current Strategies

Deborah Gueryi et al.

Summary: Drug resistant epilepsy (DRE) is defined as the persistence of seizures despite at least two syndrome-adapted antiseizure drugs. Patients with DRE may benefit from non-pharmacological therapies in addition to optimizing drug management. Surgery may provide long-term seizure freedom for patients with drug resistant focal epilepsy. Comprehensive care adaptations are crucial for improving quality of life in DRE patients.

NEUROPSYCHIATRIC DISEASE AND TREATMENT (2021)

Review Neurosciences

Neuropharmacology of Antiseizure Drugs

Tahir Hakami

Summary: The choice of antiseizure drugs depends on the type of seizures. Practical guidelines have been published for selecting ASDs in patients with new-onset and drug-resistant epilepsy. Newer-generation drugs are better tolerated but have similar efficacy compared with older drugs.

NEUROPSYCHOPHARMACOLOGY REPORTS (2021)

Article Clinical Neurology

Tonic-clonic seizures in idiopathic generalized epilepsies: Prevalence, risk factors, and outcome

Ali A. Asadi-Pooya et al.

ACTA NEUROLOGICA SCANDINAVICA (2020)

Review Biochemistry & Molecular Biology

Structural, Molecular, and Functional Alterations of the Blood-Brain Barrier during Epileptogenesis and Epilepsy: A Cause, Consequence, or Both?

Wolfgang Loescher et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Review Clinical Neurology

Cannabidiol efficacy and clobazam status: A systematic review and meta-analysis

Simona Lattanzi et al.

EPILEPSIA (2020)

Article Clinical Neurology

Laser Interstitial Thermal Therapy for Epileptogenic Periventricular Nodular Heterotopia

Alexander C. Whiting et al.

WORLD NEUROSURGERY (2020)

Review Clinical Neurology

Psychogenic Non-epileptic Seizures and Pseudo-Refractory Epilepsy, a Management Challenge

Francesca Anzellotti et al.

FRONTIERS IN NEUROLOGY (2020)

Article Clinical Neurology

How to diagnose and treat post-stroke seizures and epilepsy

Johan Zelano et al.

EPILEPTIC DISORDERS (2020)

Review Pharmacology & Pharmacy

Drug Resistance in Epilepsy: Clinical Impact, Potential Mechanisms, and New Innovative Treatment Options

Wolfgang Loescher et al.

PHARMACOLOGICAL REVIEWS (2020)

Article Clinical Neurology

Anterior temporal encephaloceles: Elusive, important, and rewarding to treat

Gabrielle T. Tse et al.

EPILEPSIA (2020)

Article Behavioral Sciences

A scale for prediction of response to AEDs in patients with MRI-negative epilepsy

Shi-jun Yang et al.

EPILEPSY & BEHAVIOR (2019)

Review Clinical Neurology

Identifying mutations in epilepsy genes: Impact on treatment selection

Piero Perucca et al.

EPILEPSY RESEARCH (2019)

Article Clinical Neurology

Vagus Nerve Stimulation for the Treatment of Epilepsy

Herman F. J. Gonzalez et al.

NEUROSURGERY CLINICS OF NORTH AMERICA (2019)

Review Medicine, General & Internal

Risk factors for drug-resistant epilepsy A systematic review and meta-analysis

Wang Xue-Ping et al.

MEDICINE (2019)

Review Clinical Neurology

Lennox-Gastaut syndrome: a comprehensive review

Ali A. Asadi-Pooya

NEUROLOGICAL SCIENCES (2018)

Article Clinical Neurology

Stereotactic laser amygdalohippocampotomy for mesial temporal lobe epilepsy

Robert E. Gross et al.

ANNALS OF NEUROLOGY (2018)

Article Medicine, General & Internal

Surgery for Drug-Resistant Epilepsy in Children

Rekha Dwivedi et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

Review Clinical Neurology

Drug-Resistant epilepsy: Multiple Hypotheses, Few Answers

Fei Tang et al.

FRONTIERS IN NEUROLOGY (2017)

Review Clinical Neurology

The possible use of the L-type calcium channel antagonist verapamil in drug-resistant epilepsy

Francesco Nicita et al.

EXPERT REVIEW OF NEUROTHERAPEUTICS (2016)

Review Clinical Neurology

The possible use of the L-type calcium channel antagonist verapamil in drug-resistant epilepsy

Francesco Nicita et al.

EXPERT REVIEW OF NEUROTHERAPEUTICS (2016)

Review Behavioral Sciences

Status epilepticus, blood-brain barrier disruption, inflammation, and epileptogenesis

Jan A. Gorter et al.

EPILEPSY & BEHAVIOR (2015)

Article Clinical Neurology

Early seizures after intracerebral hemorrhage predict drug-resistant epilepsy

Bianca T. A. de Greef et al.

JOURNAL OF NEUROLOGY (2015)

Article Clinical Neurology

A pilot double-blind trial using verapamil as adjuvant therapy for refractory seizures

Felippe Borlot et al.

EPILEPSY RESEARCH (2014)

Review Clinical Neurology

Enzyme induction with antiepileptic drugs: Cause for concern?

Martin J. Brodie et al.

EPILEPSIA (2013)

Article Clinical Neurology

Predicting pharmacoresistance in pediatric epilepsy

Elaine C. Wirrell

EPILEPSIA (2013)

Article Behavioral Sciences

Adjunctive use of verapamil in patients with refractory temporal lobe epilepsy: A pilot study

Ali A. Asadi-Pooya et al.

EPILEPSY & BEHAVIOR (2013)

Review Clinical Neurology

Prognostic factors for medically intractable epilepsy: A systematic review

Merel Wassenaar et al.

EPILEPSY RESEARCH (2013)

Article Clinical Neurology

A clinical study of syndromes of idiopathic (genetic) generalized epilepsy

Ali A. Asadi-Pooya et al.

JOURNAL OF THE NEUROLOGICAL SCIENCES (2013)

Article Clinical Neurology

Levetiracetam may favorably affect seizure outcome after temporal lobectomy

Lara E. Jehi et al.

EPILEPSIA (2012)

Article Behavioral Sciences

Reasons for uncontrolled seizures in children: The impact of pseudointractability

Ali A. Asadi-Pooya et al.

EPILEPSY & BEHAVIOR (2012)

Article Medicine, General & Internal

Early Surgical Therapy for Drug-Resistant Temporal Lobe Epilepsy A Randomized Trial

Jerome Engel et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)

Article Clinical Neurology

Patterns of treatment response in newly diagnosed epilepsy

M. J. Brodie et al.

NEUROLOGY (2012)

Article Medicine, Research & Experimental

A new hypothesis of drug refractory epilepsy: Neural network hypothesis

Min Fang et al.

MEDICAL HYPOTHESES (2011)

Review Clinical Neurology

Surgical outcomes in lesional and non-lesional epilepsy: A systematic review and meta-analysis

Jose F. Tellez-Zenteno et al.

EPILEPSY RESEARCH (2010)

Article Clinical Neurology

Results of treatment changes in patients with apparently drug-resistant chronic epilepsy

Anna L. Luciano et al.

ANNALS OF NEUROLOGY (2007)

Article Clinical Neurology

Likelihood of seizure remission in an adult population with refractory epilepsy

Brian C. Callaghan et al.

ANNALS OF NEUROLOGY (2007)

Article Medicine, Research & Experimental

Potentiation of anti-epileptic drugs effectiveness by pyronaridine in refractory epilepsy

Ali Akbar Asadi-Pooya et al.

MEDICAL HYPOTHESES (2007)

Article Clinical Neurology

Genetics of drug resistance

SM Sisodiya

EPILEPSIA (2005)

Article Clinical Neurology

Increased expression of GABAA receptor β-subunits in the hippocampus of patients with temporal lobe epilepsy

S Pirker et al.

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2003)

Article Clinical Neurology

A novel mechanism underlying drug resistance in chronic epilepsy

S Remy et al.

ANNALS OF NEUROLOGY (2003)

Article Medicine, General & Internal

A randomized, controlled trial of surgery for temporal-lobe epilepsy

S Wiebe et al.

NEW ENGLAND JOURNAL OF MEDICINE (2001)